Fei Huang
About
Fei Huang is a scholar working on Molecular Biology, Cancer Research and Oncology.
According to data from OpenAlex, Fei Huang has authored 190 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 56 papers in Cancer Research and 49 papers in Oncology. Recurrent topics in Fei Huang's work include Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (17 papers) and TGF-β signaling in diseases (16 papers). Fei Huang is often cited by papers focused on Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (17 papers) and TGF-β signaling in diseases (16 papers). Fei Huang collaborates with scholars based in China, United States and Germany. Fei Huang's co-authors include Ye‐Guang Chen, Moshe Talpaz, John Nicoll, Charles L. Sawyers, Hagop M. Kantarjian, Arthur P. DeCillis, Nicholas J. Donato, Jörge E. Cortes, Ron Paquette and Claude Nicaise and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.
In The Last Decade
Fei Huang
186 papers receiving 6.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fei Huang China | 35 | 3.2k | 1.7k | 1.5k | 1.3k | 977 | 190 | 6.5k | ||
| Shinya Kimura Japan | 45 | 2.6k 0.8× | 2.1k 1.3× | 683 0.5× | 2.1k 1.7× | 1.3k 1.3× | 427 | 7.1k | ||
| Anne‐Marie Mes‐Masson Canada | 50 | 4.4k 1.4× | 2.7k 1.7× | 1.9k 1.3× | 741 0.6× | 515 0.5× | 272 | 9.1k | ||
| Yohei Miyagi Japan | 47 | 3.4k 1.1× | 2.3k 1.4× | 1.8k 1.2× | 1.0k 0.8× | 482 0.5× | 324 | 8.2k | ||
| Martin Sattler United States | 55 | 4.3k 1.3× | 2.4k 1.4× | 764 0.5× | 3.1k 2.5× | 1.5k 1.6× | 151 | 8.6k | ||
| Gerard C. Blobe United States | 52 | 6.6k 2.0× | 3.0k 1.8× | 1.4k 1.0× | 399 0.3× | 456 0.5× | 135 | 10.4k | ||
| Kojo S.J. Elenitoba‐Johnson United States | 47 | 3.7k 1.1× | 2.0k 1.2× | 679 0.5× | 876 0.7× | 1.1k 1.1× | 190 | 7.9k | ||
| Matthew L. Sherman United States | 41 | 3.2k 1.0× | 2.1k 1.3× | 671 0.5× | 1.5k 1.2× | 849 0.9× | 134 | 7.8k | ||
| Alfredo Molinolo United States | 60 | 5.0k 1.6× | 3.8k 2.3× | 1.7k 1.2× | 340 0.3× | 606 0.6× | 171 | 10.2k | ||
| Sanford A. Stass United States | 44 | 3.7k 1.1× | 1.8k 1.1× | 1.9k 1.3× | 2.3k 1.8× | 828 0.8× | 143 | 7.5k | ||
| Bruce A. Keyt United States | 31 | 5.1k 1.6× | 950 0.6× | 1.6k 1.1× | 1.7k 1.3× | 730 0.7× | 79 | 9.9k |
Countries citing papers authored by Fei Huang
Since
Specialization
Citations
This map shows the geographic impact of Fei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Huang more than expected).
Fields of papers citing papers by Fei Huang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Fei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Huang. The network helps show where Fei Huang may publish in the future.
Co-authorship network of co-authors of Fei Huang
This figure shows the co-authorship network connecting the top 25 collaborators of Fei Huang. A scholar is included among the top collaborators of Fei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Huang. Fei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Wang, Bo, Fei Huang, Rebecca L. Schneider, et al.. (2025). Dead-fallen shrubs improve soil quality and promote herb seedling settlement in an arid sandy land of northern China. Geoderma. 460. 117447–117447.
2.
Chang, Jun, et al.. (2025). Self-Assembled Drug Nanocomplexes Reverses Tumor Thermoresistance and Depletes GSH to Optimize Mild Photothermal Therapy for Osteosarcoma. ACS Applied Nano Materials. 8(26). 13475–13489.
3.
Gao, Jing, Fei Huang, Miho Matsuda, et al.. (2024). Phosphorylation of Serine 536 of p65(RelA) Downregulates Inflammatory Responses. Inflammation. 48(3). 1499–1512.
4.
Gao, Limin, Chen Zhang, Naili Zhang, et al.. (2024). Serum response factor promoting axonal regeneration by activating the Ras–Raf‐Cofilin signaling pathway after the spinal cord injury. CNS Neuroscience & Therapeutics. 30(2). e14585–e14585.
5.
Vallejo, Milene C., Fei Huang, Samuel Payne, et al.. (2023). A proteomic meta-analysis refinement of plasma extracellular vesicles. Scientific Data. 10(1). 837–837.
6.
Xu, Xiaojing, Fei Huang, Hao Wang, et al.. (2021). Cross‐platform comparison of next‐generation sequencing and matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients. Journal of Clinical Laboratory Analysis. 35(9). e23818–e23818.
7.
Pei, Jie, Fei Huang, Qiong Wu, et al.. (2019). Codon optimization of G protein enhances rabies virus-induced humoral immunity. Journal of General Virology. 100(8). 1222–1233.
8.
Chen, Ruiqing, Zeng Wang, Ruilong Lan, et al.. (2018). Influence of POLG on Radiosensitivity of Nasopharyngeal Carcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 33(4). 146–154.
9.
Huang, Fei, Chang Han, Ann Greer, et al.. (2014). IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines. Molecular Cancer Therapeutics. 14(2). 620–630.
10.
Zhang, Yuqiang, Ting Tian, Luping Zhang, et al.. (2014). Mst3b Promotes Spinal Cord Neuronal Regeneration by Promoting Growth Cone Branching Out in Spinal Cord Injury Rats. Molecular Neurobiology. 51(3). 1144–1157.
11.
Huang, Fei, Lian Xu, & Shirin Khambata‐Ford. (2012). Correlation between Gene Expression of IGF-1R Pathway Markers and Cetuximab Benefit in Metastatic Colorectal Cancer. Clinical Cancer Research. 18(4). 1156–1166.
12.
Li, Dawei, Zhihai Peng, Huamei Tang, et al.. (2011). KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis. Clinical Cancer Research. 17(11). 3558–3568.
13.
Hou, Xiaonan, Fei Huang, Joan M. Carboni, et al.. (2011). Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924. Molecular Cancer Therapeutics. 10(1). 117–125.
14.
Hou, Xiaonan, Fei Huang, Luciana F. Macedo, et al.. (2011). Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer. Cancer Research. 71(24). 7597–7607.
15.
Litzenburger, Beate C., Chad J. Creighton, Anna Tsimelzon, et al.. (2010). High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy. Clinical Cancer Research. 17(8). 2314–2327.
16.
Huang, Fei, Warren Hurlburt, Ann Greer, et al.. (2010). Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model. Cancer Research. 70(18). 7221–7231.
17.
Moulder, Stacy, Kai Yan, Fei Huang, et al.. (2010). Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy. Molecular Cancer Therapeutics. 9(5). 1120–1127.
18.
DiFeo, Analisa, Fei Huang, Jaya Sangodkar, et al.. (2009). KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model. Cancer Research. 69(11). 4733–4741.
19.
Huang, Fei, Ann Greer, Warren Hurlburt, et al.. (2008). The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors. Cancer Research. 69(1). 161–170.
20.
Huang, Fei, Karen A. Reeves, Xia Han, et al.. (2007). Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection. Cancer Research. 67(5). 2226–2238.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Shinya Kimura Breakdown of academic impact, for papers by Anne‐Marie Mes‐Masson Breakdown of academic impact, for papers by Yohei Miyagi Breakdown of academic impact, for papers by Martin Sattler Breakdown of academic impact, for papers by Gerard C. Blobe Breakdown of academic impact, for papers by Kojo S.J. Elenitoba‐Johnson Breakdown of academic impact, for papers by Matthew L. Sherman Breakdown of academic impact, for papers by Alfredo Molinolo Breakdown of academic impact, for papers by Sanford A. Stass Breakdown of academic impact, for papers by Bruce A. Keyt